发明名称 |
METABOLITES OF 2-(FURAN-2-YL)-7-(2-(4-(4-(2-METHOXYETHOXY)PHENYL)PIPERAZIN-1-YL)ETHYL)-7H-PYRAZOLO[4,3-e][1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-5-AMINE AND THEIR UTILITY AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
摘要 |
<p>The present invention provides a compound of the (formula:(I) or a pharmaceutically acceptable salt thereof in isolated and purified form. The compound is an adenosine A2a receptor antagonists useful in treatment of central nervous system disorders, such as Parkinsons disease, Extra-Pyramidal Syndrome (EPS) caused by treatment with an antipsychotic agent, restless legs syndrome, Huntington s disease, attention disorders, depression, stroke and psychoses.</p> |
申请公布号 |
WO2012135084(A1) |
申请公布日期 |
2012.10.04 |
申请号 |
WO2012US30503 |
申请日期 |
2012.03.26 |
申请人 |
MERCK SHARP & DOHME CORP.;TING, PAULINE, C.;MA, SHUGUANG;BLUMENKRANTZ, NEIL;CHOWDBURY, SWAPAN;NEUSTADT, BERNARD, R. |
发明人 |
TING, PAULINE, C.;MA, SHUGUANG;BLUMENKRANTZ, NEIL;CHOWDBURY, SWAPAN;NEUSTADT, BERNARD, R. |
分类号 |
A01N43/54;C07D239/42;C07D471/04 |
主分类号 |
A01N43/54 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|